-
GNC absolved of wrongdoing in case against USPLabs
PITTSBURGH — As part of an agreement with the Department of Justice in connection with that agency's investigation into USPLabs, GNC Holdings has been absolved of knowingly selling products in violation of the Food, Drug and Cosmetic Act, the specialty channel retailer announced Wednesday.
-
Report: AstraZeneca to shed 700 U.S. jobs
WILMINGTON, Dela. — AstraZeneca is set to eliminate some 700 positions in the U.S. by the early months of 2017, according to reports. The company told USA Today the cuts would take effect Feb. 10, with its Fairfax, Delaware headquarters seeing about 120 of the expected cuts, with other impacted roles spanning those that are field-based in both sales and non-sales.